$18
The commercialization of addictive substances is big business, and the companies that market them rely on high customer retention to ensure a steady revenue flow. Big pharma has no desire for addicts of their products to break free and find serenity through abstinence. The hypocrisy of the medical establishment has practitioners simultaneously denouncing addiction while prescribing substances to ensure it.